Livebetter Trial The purpose of the livebetter study is to find out which type of heart medications (beta blockers or calcium channel blockers) contributes to a better quality of life in older adults with heart pain. quality of life includes function, symptoms, and help with day to day activities. Single blind, randomized (1:1) pragmatic trial comparing beta blocker therapy versus calcium channel blocker therapy in older adults with symptomatic sihd and mcc with plans to initiate medical treatment with anti anginal therapy.
Livebetter Trial The purpose of the livebetter study is to learn how older patients with heart disease tolerate the two primary medication groups that are currently available to treat symptoms of angina. The livebetter trial is a clinical research study comparing the effectiveness of beta blockers and calcium channel blockers in the treatment of cardiovascular disease among older adults. the goal of the study is to improve treatment strategies and quality of life for this population. Single blind, randomized (1:1) pragmatic trial comparing beta blocker therapy versus calcium channel blocker therapy in older adults with symptomatic sihd and mcc with plans to initiate medical treatment with anti anginal therapy. The exploratory aims of the neurocognitive ancillary study will be to compare the effect of bb vs. ccb on the rate of cognitive decline and incidence of mild cognitive impairment (mci) and probable dementia among older adults with stable angina and mcc in the livebetter randomized clinical trial.
Livebetter Trial Single blind, randomized (1:1) pragmatic trial comparing beta blocker therapy versus calcium channel blocker therapy in older adults with symptomatic sihd and mcc with plans to initiate medical treatment with anti anginal therapy. The exploratory aims of the neurocognitive ancillary study will be to compare the effect of bb vs. ccb on the rate of cognitive decline and incidence of mild cognitive impairment (mci) and probable dementia among older adults with stable angina and mcc in the livebetter randomized clinical trial. The purpose of the livebetter study is to find out which group of heart medications (bb or ccb) have better outcomes in older adults with stable angina. this includes looking at things that older adults think are important, such as quality of life, function, and day to day activities. Single blind, randomized (1:1) pragmatic trial comparing beta blocker therapy versus calcium channel blocker therapy in older adults with symptomatic sihd and mcc with plans to initiate medical treatment with anti anginal therapy. Single blind, randomized (1:1) pragmatic trial comparing beta blocker therapy versus calcium channel blocker therapy in older adults with symptomatic sihd and mcc with plans to initiate medical treatm. Livebetter: a trial comparing medications in older adults with stable angina and multiple chronic conditions.
Comments are closed.